Dokument: Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration

Titel:Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=68727
URN (NBN):urn:nbn:de:hbz:061-20250220-124345-6
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Polzin, Amin [Autor]
Benkhoff, Marcel [Autor]
Thienel, Manuela [Autor]
Barcik, Maike [Autor]
Mourikis, Philipp [Autor]
Shchurovska, Khrystyna [Autor]
Helten, Carolin [Autor]
Ehreiser, Vincent [Autor]
Zhe, Zhang [Autor]
Wulffen, Franziska von [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]3,10 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 20.02.2025 / geändert 20.02.2025
Stichwörter:factor Xa, thromboinflammation, myocardial infarction, platelets
Beschreibung:Background
Immediate activated factor (F)X (FXa) inhibition exerts direct antiplatelet effects in the context of arterial thrombosis but little is known about the impact of long-term therapy on platelet function in ischemic cardiovascular diseases.
Objectives
Therefore, we analyzed platelet-derived effects of long-term FXa inhibition in the setting of acute myocardial infarction (AMI) and stroke.
Methods
We evaluated the effect of acute versus chronic FXa inhibition on thromboinflammation following AMI and stroke in mice in vivo. Mechanistically, we identified changes in platelet gene expression and proteome under chronic FXa nonvitamin K antagonist oral anticoagulant treatment and characterized its functional consequence on platelet physiology. In a prospectively recruited cohort of patients with AMI, we determined cardiovascular magnetic resonance based cardiac endpoints under FXa nonvitamin K antagonist oral anticoagulant effects on clinical endpoints in a cohort of patients with AMI.
Results
Chronic but not acute FXa inhibition reduced cerebral and myocardial infarct size and improved cardiac function 24 hours after AMI in mice. Mechanistically, we identified an attenuated thromboinflammatory response with reduced neutrophil extracellular trap formation in mice and patient samples. Proteome and RNA expression analysis of FXa inhibitor treated patients revealed a reduction of key regulators within the membrane trafficking and secretion machinery hampering platelet α and dense granule release. Subsequent, thromboinflammatory neutrophil extracellular trap density in thrombi isolated from stroke and myocardial infarction patients was reduced. Patients with AMI treated with FXa inhibitors showed decreased infarct size after myocardial infarction compared to patients without anticoagulation treatment.
Conclusion
Long-term FXa inhibition induces antithromboinflammatory proteome signatures in platelets, improving infarct size after myocardial infarction and stroke.
Rechtliche Vermerke:Originalveröffentlichung:
Polzin, A., Benkhoff, M., Thienel, M., Barcik, M., Mourikis, P., Shchurovska, K., Helten, C., Ehreiser, V., Zhe, Z., von Wulffen, F., Theiss, A., Peri, S., Cremer, S., Ahlbrecht, S., Zako, S., Wildeis, L., Al-Kassis, G., Metzen, D., Utz, A., … Petzold, T. (2024). Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration. Journal of Thrombosis and Haemostasis, 23(2), 668–683. https://doi.org/10.1016/j.jtha.2024.10.025
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:20.02.2025
Dateien geändert am:20.02.2025
english
Benutzer
Status: Gast
Aktionen